Anemia, AplasticBone Marrow TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningAntilymphocyte SerumTransplantation, AutologousBone MarrowTransplantation ChimeraTissue DonorsHematologic NeoplasmsBone Marrow CellsPeripheral Blood Stem Cell TransplantationImmunosuppressive AgentsHistocompatibility TestingTreatment OutcomeBusulfanGraft SurvivalLeukemiaWhole-Body IrradiationHistocompatibilityRecurrenceStem CellsRemission InductionGraft vs Leukemia EffectCyclosporineCyclophosphamideLiver TransplantationVidarabineHematopoietic Stem CellsMyelodysplastic SyndromesGraft vs Tumor EffectMyeloablative AgonistsRetrospective StudiesLeukemia, Myeloid, AcuteSurvival AnalysisCord Blood Stem Cell TransplantationCombined Modality TherapyImmunosuppressionAnemiaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHLA AntigensLymphocyte TransfusionSurvival RateSiblingsTime FactorsGraft RejectionLymphocyte DepletionPrecursor Cell Lymphoblastic Leukemia-LymphomaMultiple MyelomaCytomegalovirus InfectionsKidney TransplantationHepatic Veno-Occlusive DiseaseDisease-Free SurvivalFollow-Up StudiesGraft vs Host ReactionHematopoiesisSalvage TherapyBone and BonesTransplantation, IsogeneicAcute DiseaseMinor Histocompatibility AntigensT-LymphocytesGranulocyte Colony-Stimulating FactorOxymetholoneMelphalanHematologic DiseasesNeoplasm, ResidualLeukemia, MyeloidAntineoplastic Combined Chemotherapy ProtocolsTransplantation ImmunologyInfectionChimerismBone Marrow PurgingVirus ActivationLymphoma, Non-HodgkinBone Marrow DiseasesHematopoietic Stem Cell MobilizationCell TransplantationPrognosisMesenchymal Stem Cell TransplantationHeart TransplantationAntigens, CD34CytarabineLeukocyte TransfusionLiving DonorsMice, Inbred C57BLPancytopeniaHemoglobinuria, ParoxysmalCytomegalovirusNuclear FamilyBlood TransfusionPrimary MyelofibrosisFatal OutcomeImmunocompromised HostCell DifferentiationLung TransplantationHodgkin Disease